{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:31:54Z","timestamp":1782552714835,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"colorado senate","award":["SB17-074"],"award-info":[{"award-number":["SB17-074"]}]},{"DOI":"10.13039\/100011866","name":"cctsi","doi-asserted-by":"crossref","award":["UL1 TR002535"],"award-info":[{"award-number":["UL1 TR002535"]}],"id":[{"id":"10.13039\/100011866","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As Colorado ranked among the top nationally in non-medical use of opioids, a pilot medication for opioid use disorder (MOUD) program was developed to increase the number of NPs and PAs providing MOUD in order to bring this evidence- based treatment to 2 counties showing disproportionally high opioid overdose deaths. Over the first 18\u2009months, the MOUD Pilot Program led to 15 new health care providers receiving MOUD waiver training and 1005 patients receiving MOUD from the 3 participating organizations. Here we evaluate patient centered clinical and functional outcomes of the pilot MOUD program implemented in 2 rural counties severely affected by the opioid crisis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Under state-funded law (Colorado Senate Bill 17\u2013074), three rural agencies submitted de-identified patient-level data at baseline (\n                      <jats:italic>N<\/jats:italic>\n                      \u00a0=\u20091005) and after 6\u2009months of treatment (\n                      <jats:italic>N<\/jats:italic>\n                      \u00a0=\u2009190, 25%) between December 2017 and January 2020. The Addiction Severity Index, PhQ9 and GAD-7 with McNemar-Bowker, and Wilcoxon Signed Rank tests analysis were used to measure patient outcomes across after participation in the program. .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients in treatment reported using less heroin (52.1% vs 20.4%), opioids (22.3% vs 11.0%), and alcohol (28.6% vs 13.1%, all\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u20090.01). Patients reported improved health (53.4% vs. 68.2%,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.04), less frequency of disability (8.69 vs. 6.51,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.02), symptoms (29.8% vs 21.3%), pain (67.5% to 53.6), worry (45.3% vs 62.3%), anxiety (49.7% vs 23.2%), depression (54.1% vs 23.3%, all\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u20090.02) after treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study shows decreased substance use, improved physical and mental health, and reduced symptoms after 6\u2009months of MOUD. Although more research on retention and long-term effects is needed, data shows improved health outcomes after 6\u2009months of MOUD. Lessons learned from implementing this pilot program informed program expansion into other rural areas in need to address some of Colorado\u2019 major public health crises.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13011-021-00424-4","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T05:04:48Z","timestamp":1641186288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2825-2659","authenticated-orcid":false,"given":"Claudia R.","family":"Amura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya R.","family":"Sorrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Beste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Hollins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"issue":"5","key":"424_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M17-0865","volume":"167","author":"B Han","year":"2017","unstructured":"Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.s. adults: 2015 National Survey on drug use and health. Ann Intern Med. 2017;167(5):293\u2013301. https:\/\/doi.org\/10.7326\/M17-0865.","journal-title":"Ann Intern Med"},{"key":"424_CR2","unstructured":"Centers for Disease Control and Prevention. Drug overdose deaths. https:\/\/www.cdc.gov\/drugoverdose\/deaths\/index.html Accessed Nov 2021."},{"issue":"10 Suppl","key":"424_CR3","first-page":"S200","volume":"24","author":"NE Hagemeier","year":"2018","unstructured":"Hagemeier NE. Introduction to the opioid epidemic: the economic burden on the healthcare system and impact on quality of life. Am J Manag Care. 2018;24(10 Suppl):S200\u2013s206 PMID: 29851449.","journal-title":"Am J Manag Care"},{"key":"424_CR4","unstructured":"US Department of Health and Human Services. Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. Washington, DC; 2016. https:\/\/addiction.surgeongeneral.gov\/sites\/default\/files\/surgeon-generals-report.pdf accessed Nov 2021"},{"key":"424_CR5","unstructured":"American Hospital Association. Rural Report. Challenges facing rural communities and the roadmap to ensure local access to high-quality, affordable care. 2019. https:\/\/www.aha.org\/system\/files\/2019-02\/rural-report-2019.pdf; accessed Nov 2021."},{"key":"424_CR6","unstructured":"Hedegaard, H, and Spencer, M.R, U.S. Department of health and human services. Centers for disease control and prevention. National Center for Health Statistics. Urban\u2013rural differences in trends in overdose deaths varied by type of opioid and over time across the country https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db403-H.pdf; Accessed August 2021."},{"key":"424_CR7","unstructured":"Colorado Health Institute. Miles away from Help. The Opioid Epidemic and Medicaiton-Assisted Treatment in Colorado. 2017. https:\/\/www.coloradohealthinstitute.org\/sites\/default\/files\/file_attachments\/2017%20MAT%20report.pdf accessed Nov 2021."},{"key":"424_CR8","unstructured":"Colorado Health Institute. The Colorado Health Access Survey: Progress in Peril. 2019.https:\/\/www.coloradohealthinstitute.org\/sites\/default\/files\/file_attachments\/CHAS%20Storybook%202019%20for%20Web.pdf; accessed Nov 2021."},{"key":"424_CR9","unstructured":"Substance Abuse and Mental Health Services Administration. Medicantion-Assisted Treatment (MAT) guidance documents. https:\/\/www.samhsa.gov\/medication-assisted-treatment; accessed Nov 2021."},{"issue":"1","key":"424_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jrh.12307","volume":"35","author":"CHA Andrilla","year":"2019","unstructured":"Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update. J Rural Health. 2019;35(1):108\u201312. https:\/\/doi.org\/10.1111\/jrh.12307.","journal-title":"J Rural Health"},{"key":"424_CR11","doi-asserted-by":"publisher","unstructured":"Moore, DJ. Nurse Practitioner\u2019s pivotal role in ending the opioid epidemic. J Nurs Pract 2019;15(5):P323-P327, 323, https:\/\/doi.org\/10.1016\/j.nurpra.2019.01.005.","DOI":"10.1016\/j.nurpra.2019.01.005"},{"key":"424_CR12","doi-asserted-by":"publisher","first-page":"108027","DOI":"10.1016\/j.jsat.2020.108027","volume":"114","author":"TR Sorrell","year":"2020","unstructured":"Sorrell TR, Weber M, Alvarez A, Beste N, Hollins U, Amura CR, et al. From policy to practice: pilot program increases access to medication for opioid use disorder in rural Colorado. J Subst Abus Treat. 2020;114:108027. https:\/\/doi.org\/10.1016\/j.jsat.2020.108027.","journal-title":"J Subst Abus Treat"},{"issue":"3","key":"424_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-s","volume":"9","author":"AT McLellan","year":"1992","unstructured":"McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the addiction severity index. J Subst Abus Treat. 1992;9(3):199\u2013213. https:\/\/doi.org\/10.1016\/0740-5472(92)90062-s.","journal-title":"J Subst Abus Treat"},{"issue":"9","key":"424_CR14","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/j.1360-0443.2011.03482.x","volume":"106","author":"JS Cacciola","year":"2011","unstructured":"Cacciola JS, Alterman AI, Habing B, McLellan AT. Recent status scores for version 6 of the addiction severity index (ASI-6). Addiction. 2011;106(9):1588\u2013602. https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03482.x.","journal-title":"Addiction"},{"issue":"9","key":"424_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"424_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.addbeh.2007.09.017","volume":"33","author":"M Dum","year":"2009","unstructured":"Dum M, Pickren J, Sobell LC. el al. Comparing the BDI-II and the PHQ-9 with outpatient substance abusers. Addict Behav. 2009;33(2):381\u20137. https:\/\/doi.org\/10.1016\/j.addbeh.2007.09.017.","journal-title":"Addict Behav"},{"issue":"10","key":"424_CR17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137. https:\/\/doi.org\/10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"},{"issue":"1\u20132","key":"424_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.drugalcdep.2012.03.011","volume":"125","author":"J Delgadillo","year":"2012","unstructured":"Delgadillo J, Payne S, Gilbody S, Godfrey C, Gore S, Jessop D, et al. Brief case finding tools for anxiety disorders: validation of GAD-7 and GAD-2 in addictions treatment. Drug Alcohol Depend. 2012;125(1\u20132):37\u201342. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.03.011.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"424_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"424_CR20","unstructured":"U.S. Bureau of Labor Statistics. 2019. https:\/\/data.bls.gov\/timeseries\/LASST080000000000004?amp%253bdata_tool=XGtable&output_view=data&include_graphs=true. Accessed Sept 2020."},{"issue":"1","key":"424_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12939-018-0773-5","volume":"17","author":"A Brydsten","year":"2018","unstructured":"Brydsten A, Hammarstr\u00f6m A, San SM. Health inequalities between employed and unemployed in northern Sweden: a decomposition analysis of social determinants for mental health. I J Equity Health. 2018;17(1):59. https:\/\/doi.org\/10.1186\/s12939-018-0773-5.","journal-title":"I J Equity Health"},{"issue":"3","key":"424_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1017\/S1368980015001603","volume":"19","author":"J Huang","year":"2016","unstructured":"Huang J, Kim Y, Birkenmaier J. Unemployment and household food hardship in the economic recession. Public Health Nutr. 2016;19(3):511\u20139. https:\/\/doi.org\/10.1017\/S1368980015001603.","journal-title":"Public Health Nutr"},{"issue":"5","key":"424_CR23","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1017\/S0033291713001621","volume":"44","author":"A Milner","year":"2014","unstructured":"Milner A, Page A, LaMontagne AD. Cause and effect in studies on unemployment, mental health and suicide: a meta-analytic and conceptual review. Psychol Med. 2014;44(5):909\u201317. https:\/\/doi.org\/10.1017\/S0033291713001621.","journal-title":"Psychol Med"},{"issue":"6","key":"424_CR24","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1360-0443.2010.02902.x","volume":"105","author":"J Swendsen","year":"2010","unstructured":"Swendsen J, Conway KP, Degenhardt L, Glantz M, Jin R, Merikangas KR, et al. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction. 2010;105(6):1117\u201328. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.02902.x.","journal-title":"Addiction"},{"issue":"2","key":"424_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054496","volume":"8","author":"GJ Unick","year":"2013","unstructured":"Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLoS One. 2013;8(2):e54496. https:\/\/doi.org\/10.1371\/journal.pone.0054496.","journal-title":"PLoS One"},{"key":"424_CR26","doi-asserted-by":"publisher","DOI":"10.17226\/25310","volume-title":"Medications for Opioid Use Disorder save lives: consensus study report","author":"National Academies of Sciences, Engineering, and Medicine","year":"2019","unstructured":"National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder save lives: consensus study report. Washington, DC: National Academies Press; 2019. https:\/\/doi.org\/10.17226\/25310."},{"issue":"7","key":"424_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1176\/appi.ajp.2018.17060688","volume":"175","author":"AG Robertson","year":"2018","unstructured":"Robertson AG, Easter MM, Lin H, Frisman LK, Swanson JW, Swartz MS. Medication-assisted treatment for alcohol-dependent adults with serious mental illness and criminal justice involvement: effects on treatment utilization and outcomes. Am J Psychiatr. 2018;175(7):665\u201373. https:\/\/doi.org\/10.1176\/appi.ajp.2018.17060688.","journal-title":"Am J Psychiatr"},{"issue":"6","key":"424_CR28","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2019.78","volume":"5","author":"I Shams","year":"2019","unstructured":"Shams I, Sanger N, Bhatt M, Rosic T, Luo C, Shahid H, et al. The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment. BJ Psych Open. 2019;5(6):e91. https:\/\/doi.org\/10.1192\/bjo.2019.78.","journal-title":"BJ Psych Open"},{"issue":"2","key":"424_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11121-018-0933-2","volume":"20","author":"A Brooks-Russell","year":"2019","unstructured":"Brooks-Russell A, Ma M, Levinson AH, Kattari L, Kirchner T, Anderson Goodell EM, et al. Adolescent marijuana use, marijuana-related perceptions, and use of other substances before and after initiation of retail marijuana sales in Colorado (2013-2015). Prev Sci. 2019;20(2):185\u201393. https:\/\/doi.org\/10.1007\/s11121-018-0933-2.","journal-title":"Prev Sci"},{"key":"424_CR30","doi-asserted-by":"publisher","unstructured":"Rich RJ, Chou R, Mariano ER, et al. Best Practices, Research Gaps, and Future Priorities to Support Tapering Patients on Long-Term Opioid Therapy for Chronic Non-Cancer Pain in Outpatient Settings. Natl Acad Med. 2020. https:\/\/doi.org\/10.31478\/202008c.","DOI":"10.31478\/202008c"},{"key":"424_CR31","unstructured":"National Academy of Medicine. Phillips JK, Ford MA, Bonnie RJ, eds. Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use. Vol 13. 2017. https:\/\/nam.edu\/best-practices-research-gaps-and-future-priorities-to-support-tapering-patients-on-long-term-opioid-therapy-for-chronic-non-cancer-pain-in-outpatient-settings\/ Washington (DC): National Academies Press (US). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK458660\/ accessed November 2021."},{"key":"424_CR32","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. https:\/\/doi.org\/10.1136\/bmj.j1550.","journal-title":"BMJ"},{"key":"424_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drugalcdep.2015.10.009","volume":"157","author":"B Nosyk","year":"2015","unstructured":"Nosyk B, Bray JW, Wittenberg E, Aden B, Eggman AA, Weiss RD, et al. Short term health-related quality of life improvement during opioid agonist treatment. Drug Alcohol Depend. 2015;157:121\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.10.009.","journal-title":"Drug Alcohol Depend"},{"key":"424_CR34","unstructured":"Prescription Drug Data Profiles. Colorado Department of Public Health and Environment. https:\/\/cdphe.colorado.gov\/prevention-and-wellness\/injury-prevention\/opioid-overdose-prevention\/prescription-drug-data. Accessed 2 Jan 2021."},{"key":"424_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2147\/JPR.S105892","volume":"9","author":"M Due\u00f1as","year":"2016","unstructured":"Due\u00f1as M, Ojeda B, Salazar A, Mico JA, Failde I. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res. 2016;9:457\u201367. https:\/\/doi.org\/10.2147\/JPR.S105892.","journal-title":"J Pain Res"},{"issue":"10","key":"424_CR36","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.addbeh.2014.05.025","volume":"39","author":"EE Hartwell","year":"2014","unstructured":"Hartwell EE, Pfeifer JG, McCauley JL, Moran-Santa Maria M, Back SE. Sleep disturbances and pain among individuals with prescription opioid dependence. Addict Behav. 2014;39(10):1537\u201342. https:\/\/doi.org\/10.1016\/j.addbeh.2014.05.025.","journal-title":"Addict Behav"},{"issue":"17","key":"424_CR37","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMp1801417","volume":"378","author":"MA Oquendo","year":"2018","unstructured":"Oquendo MA, Volkow ND. Suicide: a silent contributor to opioid-overdose deaths. N Engl J Med. 2018;378(17):1567\u20139. https:\/\/doi.org\/10.1056\/NEJMp1801417.","journal-title":"N Engl J Med"},{"key":"424_CR38","unstructured":"American Psychiatric Association. Criteria from American Psychiatric Association. In: Diagnostic and Statistical Manual of Mental Disorders. Fifth ed. Washington, DC; American Psychiatric Association Publishing; https:\/\/www.psychiatry.org\/psychiatrists\/practice\/dsm2013."},{"issue":"4","key":"424_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/ajad.12527","volume":"26","author":"AR Williams","year":"2017","unstructured":"Williams AR, Barbieri V, Mishlen K, Levin FR, Nunes EV, Mariani JJ, et al. Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders. Am J Addict. 2017;26(4):319\u201325. https:\/\/doi.org\/10.1111\/ajad.12527.","journal-title":"Am J Addict"},{"issue":"1","key":"424_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","volume":"35","author":"C Timko","year":"2016","unstructured":"Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: a systematic review. J Addict Dis. 2016;35(1):22\u201335. https:\/\/doi.org\/10.1080\/10550887.2016.1100960.","journal-title":"J Addict Dis"},{"issue":"1","key":"424_CR41","doi-asserted-by":"publisher","first-page":"16(8)","DOI":"10.1186\/s13011-021-00342-5","volume":"16","author":"AC Lynch","year":"2021","unstructured":"Lynch AC, Weber AN, Hedden S, Sabbagh S, Arndt S, Acion L. Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA. Subst Abuse Treat Prev Policy. 2021;16(1):16(8). https:\/\/doi.org\/10.1186\/s13011-021-00342-5.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"424_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.addbeh.2017.05.010","volume":"73","author":"AJ Damian","year":"2017","unstructured":"Damian AJ, Mendelson T, Agus D. Predictors of buprenorphine treatment success of opioid dependence in two Baltimore City grassroots recovery programs. Addict Behav. 2017;73:129\u201332. https:\/\/doi.org\/10.1016\/j.addbeh.2017.05.010.","journal-title":"Addict Behav"},{"issue":"8","key":"424_CR43","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1176\/appi.ajp.2016.16070792","volume":"174","author":"KM Carroll","year":"2016","unstructured":"Carroll KM, Weiss RD. The role of behavioral interventions in buprenorphine maintenance treatment: a review. Am J Psychiatr. 2016;174(8):738-747183-192\u201347. https:\/\/doi.org\/10.1176\/appi.ajp.2016.16070792.","journal-title":"Am J Psychiatr"},{"issue":"10182","key":"424_CR44","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","volume":"393","author":"C Blanco","year":"2019","unstructured":"Blanco C, Volkow ND. Management of opioid use disorder in the USA: present status and future directions. Lancet. 2019;393(10182):1760\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(18)33078-2.","journal-title":"Lancet"},{"issue":"5","key":"424_CR45","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2105\/AJPH.2012.301056","volume":"103","author":"C Henderson","year":"2013","unstructured":"Henderson C, Evans-Lacko S, Thornicroft G. Mental illness stigma, help seeking, and public health programs. Am J Public Health. 2013;103(5):777\u201380. https:\/\/doi.org\/10.2105\/AJPH.2012.301056.","journal-title":"Am J Public Health"},{"issue":"2","key":"424_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/bjc.12128","volume":"56","author":"C von Hippel","year":"2017","unstructured":"von Hippel C, Henry JD, Terrett G, Mercuri K, McAlear K, Rendell PG. Stereotype threat and social function in opioid substitution therapy patients. Br J Clin Psychol. 2017;56(2):160\u201371. https:\/\/doi.org\/10.1111\/bjc.12128.","journal-title":"Br J Clin Psychol"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00424-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-021-00424-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-021-00424-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T05:07:12Z","timestamp":1641186432000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-021-00424-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1186\/s13011-021-00424-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-769124\/v1","asserted-by":"object"}]},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]},"assertion":[{"value":"19 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As an evaluation of pilot program implementation, this study was regarded as non-human subjects research by the Colorado IRB (protocol #19\u20132217). In compliance with ethical standards for human subject\u2019s studies, however, all individual-level data was collected at clinical sites to guide treatment; only aggregated, de-identified was used in this study. Patients had the right to refuse providing data for evaluation. Administrative, site-level data about characteristics of opioid treatment programs was also used as part of the evaluation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}